Summary
This prediction ended on 28.12.15 with a price of €116.10. The price of Bayer AG has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -12.01%. exploration has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bayer AG | -8.069% | -8.069% | 82.520% | -28.805% |
| iShares Core DAX® | 1,23 % | 1,50 % | 11,29 % | 63,49 % |
| iShares Nasdaq 100 | 0,69 % | -1,95 % | 5,59 % | 88,83 % |
| iShares Nikkei 225® | 2,08 % | 11,06 % | 31,15 % | 67,95 % |
| iShares S&P 500 | 0,42 % | 0,21 % | 4,12 % | 60,99 % |
Comments by exploration for this prediction
In the thread Bayer AG diskutieren
Bayer: langfristig positiv
Bayer ist für langfristig orientierte Anleger ein Basisinvestment. Somit können Rückschläge bis 130€ für Käufe getätigt werden. Unter 122€ wird es kritisch.
(Laufzeit überschritten)